机构地区:[1]南京中医药大学附属医院核医学科,南京210029 [2]东南大学临床医学院,南京210009
出 处:《核技术》2023年第3期34-41,共8页Nuclear Techniques
基 金:国家自然科学基金(No.81171452);江苏省自然科学基金(No.BK20131455)资助。
摘 要:为了研究^(131)I标记贝伐单抗偶联载紫杉醇超顺磁性氧化铁纳米粒(^(131)I-Bevacizumab-Paclitaxel-Superparamagnetic Iron Oxide Nanoparticles,^(131)I-BEV-PTX-SPIONs)的制备和生物学分布。将30只成瘤裸鼠分为单靶向组及双靶向组,再按时间点2 h、6 h、12 h、24 h及48 h分为5个亚组,每亚组各3只,尾静脉注射^(131)IBEV-PTX-SPIONs后,进行生物学分布及单光子发射计算机断层成像术(Single-Photon Emission Computed Tomography,SPECT)显像。^(131)I-BEV-PTX-SPIONs的粒径约220 nm,分散性尚可;^(131)I标记率为81.4%;放射性化学纯度(Radiochemical Purity,RCP)>99%;在PB缓冲液中稳定性良好;在体外PTX(Paclitaxel)缓释性能良好;与A549细胞有较好的亲和力。体内生物学分布结果:随着时间的延长,肿瘤组织的放射性计数相对增高,12 h达高峰;T/NT(Target to Nontarget)比值逐渐升高,48 h达7.80±0.50。6 h、12 h、24 h、48 h时,双靶向组的肿瘤组织放射性计数及T/NT比值均高于单靶向组,差异均具有统计学意义(P<0.05),且差异性随着时间延长越来越显著。SPECT显像结果:2 h肿瘤部位即有放射性聚集,且随着时间的延长,放射性聚集增加并持续稳定,T/NT比值持续上升。初步研究结果显示,^(131)I-BEV-PTX-SPIONs具有用于肺癌诊疗的潜质,值得进一步研究。[Background]^(131)I-BEV-PTX-SPIONs is a type of nanoparticle used in cancer therapy.It is composed of four components:a radioactive isotope of iodine(^(131)I),a chemotherapy drug called paclitaxel(PTX),a type of nanoparticle called superparamagnetic iron oxide nanoparticles(SPIONs),and a molecule called bevacizumab(BEV)which is an antibody that targets and blocks the growth of blood vessels that supply tumors.[Purpose]This study aims to investigate the preparation and biological distribution of ^(131)I-BEV-PTX-SPIONs.[Methods]First of all,^(131)I-BEV-PTX-SPIONs were prepared,synthetized and identified.The transmission electron microscope(TEM)were employed to observe the particle characteristics.Then,30 tumor-burdened nude mice were divided into the single targeting group and the dual targeting group for evaluation of ^(131)I-BEV-PTX-SPIONs distribution in these nude mice,each group was divided into five sub-groups based on time points of 2 h,6 h,12 h,24 h and 48 h,3 in each sub group.Finally,^(131)I-BEV-PTX-SPIONs were injected into the caudal vein of these mice,and experiments of biological distribution in vivo and SPECT imaging were carried out,and results were analyzed using GraphPad Prism 8.3 software.[Results]The nanospheres in prepared ^(131)I-BEV-PTX-SPIONs are obtained in good mono dispersion with a diameter of approximately 220 nm by TEM observation.^(131)I-BEV-PTX-SPIONs obtained in a high radiolabeling yield is about 81.4%with the radiochemical purity of over 99%and good stability shown in the 0.2 mol·L−1 PB buffer.And it could attain sustained PTX release in vitro.Comparing with the cellular uptake of ^(131)I,a higher uptake and sustained PTX release in vitro are shown for ^(131)I-BEV-PTX-SPIONs.Biodistribution experimental results show:After the injection of ^(131)I-BEV-PTX-SPIONs,with the extension of time,the radiation count of the tumor is relatively higher,at 12 h reaching the peak.And the T/NT ratio increased gradually,and it reaches 7.8±0.50 at 48 h.The counts and the ratios at 6 h,12 h,24
关 键 词:超顺磁性氧化铁纳米粒 紫杉醇 核素^(131)I 贝伐抗体 荷瘤裸鼠 肺癌
分 类 号:TL923[核科学技术—核燃料循环与材料]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...